Intermediate Capital Group scored an attractive IRR and an equally attractive money multiple on its exit from Amolyt Pharma given that the private equity firm invested just 14 months ago, Toby Sykes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results